Zika Virus Vaccine Candidate from Japan
Zika virus vaccine candidate is an mRNA-based or DNA vaccine platform designed for Zika flavivirus prevention, currently in clinical stages. It is a virus culture-derived prophylactic product obtained via biotechnological processes, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the vaccine candidate has an investigational new drug (IND) status or clinical trial authorization from Health Canada for import
• Classify under 3002.49.00 and provide evidence of the biotechnological process used
• Verify if the product is duty-free under the MFN tariff, but confirm with the CBSA for current rates